Home Your basket
• Treatment failures in ben...
   Price 10.50 €
• Utility of positron emiss...
   Price 8.50 €
• Wegener granulomatosis mi...
   Price 14.00 €
• Notes on voice and speech...
   Price 8.50 €
• Bilateral cochlear implan...
   Price 5.50 €
• Apology for the biplane c...
   Price 10.50 €
• Cephalic vein access for ...
   Price 10.50 €
• Nasal polyposis: long ter...
   Price 10.50 €
• Otosclerosis among patien...
   Price 10.50 €
• Rejuvenation of the eye: ...
   Price 10.50 €
• Dermatofibrosarcoma protu...
   Price 10.50 €
• The three-stage frontal f...
   Price 14.00 €
• Revision ossiculoplasty: ...
   Price 10.50 €
• Perceptual assessment of ...
   Price 10.50 €
• Efficacy and safety of mo...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Ambulatory stapedectomy: ...
   Price 8.50 €
• Evaluation of the handica...
   Price 10.50 €
• Sentinel lymph node biops...
   Price 15.00 €
• The frontal pneumosinus d...
   Price 8.50 €
• Vertebro and cranio veino...
   Price 14.00 €
• Reverse phonation: Pathol...
   Price 8.50 €
• Otoplasty: Special attent...
   Price 8.50 €
• Cosmetic radiofrequency...
   Price 10.50 €
• Interests of multimedia s...
   Price 10.50 €
• Traditional and emerging ...
   Price 10.50 €
• A comparative acoustic st...
   Price 5.50 €
• Frontal sinus osteoma com...
   Price 5.50 €
• Adenomatoid hamartoma of ...
   Price 5.50 €
• Hearing results in stapes...
   Price 10.50 €
• Bell's palsy: treatment b...
   Price 5.50 €
• Neuroplasticity in the au...
   Price 10.50 €
• Interest of MIBI scintigr...
   Price 10.50 €
• Cowden syndrome: Otolaryn...
   Price 12.00 €
• Diagnosis and treatment o...
   Price 10.50 €
• Validation of a clinical ...
   Price 10.50 €
• Characteristics of the ma...
   Price 12.50 €
• Type III ossiculoplasty w...
   Price 5.50 €
• Usher type I syndrome in ...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Autistic like behaviour d...
   Price 8.50 €
• Cytokines profile in cyst...
   Price 10.50 €
• Partial allotransplantati...
   Price 10.50 €
• Rhinoplasty: Advantages a...
   Price 10.50 €
• Evaluation of the primary...
   Price 5.50 €
• Evaluation in clinical pr...
   Price 10.50 €
• Recurrent mandibular amel...
   Price 12.50 €
• These lesions of the voca...
   Price 10.50 €
• Sacrifice was an art: The...
   Price 8.50 €
• Failure rate and revision...
   Price 10.50 €
• The domes crossover: A ne...
   Price 10.50 €
• Functional anatomy of the...
   Price 14.00 €
• Primary nasal tuberculosi...
   Price 5.50 €
• Sarcoidosis of the thyroi...
   Price 12.50 €
• Velo-pharyngeal incompete...
   Price 14.00 €
• Laryngeal schwannoma: A c...
   Price 5.50 €
• Prognostic value of senti...
   Price 10.50 €
• The symphonix symposium u...
   Price 8.50 €
• Isolated tracheo-œsophage...
   Price 5.50 €
• Unusual location of pleom...
   Price 12.50 €
• Clinical implementation o...
   Price 5.50 €
• Allergic and pneumologic ...
   Price 8.50 €
• Parapharyngeal tumours: M...
   Price 10.50 €
• A single appointment with...
   Price 8.50 €
• Disorders of the sense of...
   Price 5.50 €
• Evaluation and treatment ...
   Price 8.50 €
• Voice rehabilitation afte...
   Price 10.50 €
• Difficult blepharoplastie...
   Price 10.50 €
• Speech disorders, verbal ...
   Price 10.50 €
• Cat scratch disease: A di...
   Price 8.50 €
• Laryngeal schwannoma: A c...
   Price 8.50 €
• A remnant tooth in an ede...
   Price 8.50 €
• Chyle leak after cervical...
   Price 15.00 €
• Eagle syndrom: A case rep...
   Price 8.50 €
• Parathyroïd adenoma induc...
   Price 8.50 €
• How I do it: Salivary duc...
   Price 8.50 €
• The effectiveness of voic...
   Price 14.00 €
• Distortion product otoaco...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €

Total Order 758.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2000 o

RHINOLOGY

Acceptability of topical administration of a combination of corticoid (beclomethasone) and antihistamine (azelastine) in the treatment of allergic rhinitis.


Authors : D. Portmann, M. Le Gal, V. Jessent, J.-L. Verrière (Bordeaux, Lyon)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,4:273-280.

Article published in french
Downloadable PDF document french



Summary : A prospective multicentre study involving 219 patients with seasonal or aperiodic rhinitis was performed to assess the acceptability of a local treatment combining antihistamine (azelastine) and corticoid (beclomethasone) drugs. The drugs were administered either together (morning and evening, with a 5-minute interval) or separately (azelastine in the morning and evening, and beclomethasone later during the morning and in the afternoon) for 15 days. Treatment acceptability was measured by a nine-fold questionnaire (7-point scale, mean score per question). Patient participation, protocol and therapy compliance, and treatment efficacy and tolerance were also studied. The acceptability of the association was satisfactory (mean score for general facility of treatment: 4.7 / 6) and did not differ between administration schedules. Patients found treatment easy, and were not bothered by the bulk of the bottles or the risk of mixing them up. This acceptability was confirmed by the low percentage (4 %) of patients refusing to be included in the study (refusing any treatment by nasal spray). The general acceptability was confirmed by the results for therapy compliance, general efficacy and tolerance: 94.9 % of the patients took more than 75 % of the administrations prescribed, 77.6 % of the patients and 85.2 % of the practitioners judged treatment efficacy as good or excellent, and 84.6 % of the patients and 91.4 % of the practitioners judged tolerance as good or excellent. Moreover, most of the adverse events consisted of minor signs of local intolerance, and were identical to those observed when the two treatments were administered alone.

Price : 5.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE